📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial. (2020)

First Author: Chiesa R

Attributed to: Dose rationale for antibiotic combination therapy in infection diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1715

PubMed Identifier: 31701524

Publication URI: http://europepmc.org/abstract/MED/31701524

Type: Journal Article/Review

Volume: 108

Parent Publication: Clinical pharmacology and therapeutics

Issue: 2

ISSN: 0009-9236